1. Home
  2. LRMR vs CRAC Comparison

LRMR vs CRAC Comparison

Compare LRMR & CRAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Larimar Therapeutics Inc.

LRMR

Larimar Therapeutics Inc.

HOLD

Current Price

$3.72

Market Cap

260.1M

Sector

Health Care

ML Signal

HOLD

CRAC

Crown Reserve Acquisition Corp. I Class A Ordinary Shares

N/A

Current Price

$9.97

Market Cap

214.3M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
LRMR
CRAC
Founded
N/A
2025
Country
United States
Cayman Islands
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
260.1M
214.3M
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
LRMR
CRAC
Price
$3.72
$9.97
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$16.71
N/A
AVG Volume (30 Days)
1.2M
81.2K
Earning Date
11-05-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.61
$9.89
52 Week High
$5.37
$10.00

Technical Indicators

Market Signals
Indicator
LRMR
CRAC
Relative Strength Index (RSI) 56.32 59.32
Support Level $3.05 $9.95
Resistance Level $3.72 $10.00
Average True Range (ATR) 0.23 0.01
MACD 0.05 -0.00
Stochastic Oscillator 94.37 50.00

Price Performance

Historical Comparison
LRMR
CRAC

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

About CRAC Crown Reserve Acquisition Corp. I Class A Ordinary Shares

Crown Reserve Acquisition Corp I is a blank check company.

Share on Social Networks: